Clinical Trial: A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: Shingles
Study Type: INTERVENTIONAL
Official Title: A PHASE 1/2 RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST VARICELLA ZOSTER VIRUS IN HEALTHY INDIVIDUALS
Brief Summary:
The purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune system's reaction) of the study vaccine called Varicella Zoster Virus modRNA (VZV modRNA).We are seeking for healthy participants who are between 50 and 69 years of age.This study will be conducted in 2 substudies: Substudy A (Phase 1) and Substudy B (Phase 2).Substudy A:This substudy is the Phase 1 portion of the study.In this substudy, participants will receive…
Read more